Nicotinamide-N-methyltransferase (NNMT) Versus Its Inhibitor, a new way to promote weight loss?
Written by , Updated on May 4th, 2024
Reading Time: < 1 minute There is a critical need for new mechanism-of-action drugs that reduce the burden of obesity, osteoarthritis, cardiovascular disease, cancer, Parkinson's disease, kidney disease, metabolic disorders, and other associated chronic metabolic co-morbidities. Nicotinamide-N-methyltransferase (NNMT), is a cytosolic enzyme with newly identified cellular metabolism roles and energy homeostasis. Studies indicate that this enzyme slows down the process at which our bodies metabolize... Read more »
